STAT1 and gastric cancer: Overall, this study demonstrated that the density of CD33+/p-STAT1+ cells is an independent prognostic factor for patients with stage IIIa gastric cancer, indicating that CD33+/p-STAT1+ cells play a central role in the local immune response in gastric cancer.